MarginsXMarginsX
Home › Markets › Health Care › USNA

USANA Health Sciences Inc. (USNA)

USNA trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.54
+2.27% on the day
Market cap
$250.3M
Micro cap
Revenue · 2025
$925.3M
+8.3% on 2024
Net income · 2025
$10.8M
1.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-01-03, https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/0000896264-26-000021-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-01-03.

Profile

FieldValue
TickerUSNA on NYSE
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000896264

Financials · 2025

LineValue
Revenue$925.3M
Net income$10.8M
Operating income$37.4M
Net margin1.2%
Operating margin4.0%
Revenue growth+8.3%
Cash$158.4M
Total assets$742.9M
P/E (computed)23.3×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$178.9M cash at October 3, 2026
Share count, 1 year
+1.1%
2025-10-31 to 2026-11-06 · -3.4% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
-$991K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$178.9M cash; operating cash flow $10.4M a quarter.Report 2026-10-03
Shares outstanding18,488,751 (2026-11-06); 18,280,857 a year earlier; 19,129,806 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Salt Lake City, Utah, United StatesPCAOB Form AP 2026-04-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $991K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-10-03
$205.9M-$5.6M$12.0M$178.9MNo debt tags$905.6M10-Q 2026-11-12
Q2 2026
2026-07-04
$223.3M-$21.4M$23.3M$168.6MNo debt tags$913.4M10-Q 2026-08-13
Q1 2026
2026-04-04
$250.2M$7.5M$9.8M$162.8MNo debt tags$925.9M10-Q 2026-05-12
Q4 2025
2026-01-03
$226.2M-$1.8M-$3.4M$158.4MNo debt tags$925.3M10-K 2026-03-16
Q3 2025
2025-09-27
$213.7M-$6.5M-$2.0M$145.3MNo debt tags$912.7M10-Q 2026-11-12
Q2 2025
2025-06-28
$235.8M$9.7M$12.2M$151.3MNo debt tags$899.2M10-Q 2026-08-13
Q1 2025
2025-03-29
$249.5M$9.4M$15.5M$179.6MNo debt tags$876.2M10-Q 2026-05-12
Q4 2024
2024-12-28
$213.6M$4.5M$5.8M$181.8MNo debt tags$854.5M10-K 2026-03-16

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-2.9%
1 month-14.4%
3 months-2.9%
Year to date-32.6%
1 year-31.6%
From 52-week high-43.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier